Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Phase 1b Study of CC-90010 with Temozolomide in Adults with Newly Diagnosed Glioblastoma After Surgery
DenmarkSafety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study
DenmarkEfficacy and Safety of E2086 in Adults with Narcolepsy: A Randomized, Double‑Blind, Placebo‑Controlled Trial
BelgiumPharmacokinetics of Intravenous Lidocaine Hydrochloride in Young and Elderly Patients Undergoing Anesthesia
FranceAn exploratory study to evaluate the effect of rimonabant on hand function in patients with cervical spinal cord injury
SpainPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
AustriaEvaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster
DenmarkRelative Bioavailability of Pitolisant Tablets in Healthy Male Subjects for Narcolepsy Treatment
Belgium
CzechiaPharmacokinetics, Pharmacodynamics and Safety of Inhaled and Intravenous d,l‑lysine acetylsalicylate in Healthy Adults with Migraine
GermanyComparative Bioavailability of Inhaled Levodopa (Levodopa Cyclops) versus Inhaled Levodopa Powder with Carbidopa in Healthy Adults for Parkinson’s Disease
BulgariaSafety and Tolerability of NT-0796, Nadroparin, and Lidocaine Hydrochloride in Healthy Volunteers and Patients with Parkinson’s Disease
The NetherlandsThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
